Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Total Revenue | - | 2,615.50 | 2,567 | 2,549.30 | 2,755.40 |
| Operating Revenue | - | 2,615.50 | 2,567 | 2,549.30 | 2,755.40 |
| Cost Of Revenue | - | 735.70 | 718.50 | 692.10 | 758.50 |
| Gross Profit | - | 1,879.80 | 1,848.50 | 1,857.20 | 1,996.90 |
| Operating Expense | - | 1,408.40 | 1,295.60 | 1,396.70 | 1,995.60 |
| Research And Development | - | 472.30 | 406.40 | 403 | 426.70 |
| Selling General And Administration | - | 936.10 | 889.20 | 993.70 | 1,568.90 |
| Total Expenses | - | 2,144.10 | 2,014.10 | 2,088.80 | 2,754.10 |
| Operating Income | - | 471.40 | 552.90 | 460.50 | 1.30 |
| Total Operating Income As Reported | - | 471.40 | 501.60 | 391.60 | -5.10 |
| EBITDA | - | 640.30 | 704.30 | 601.40 | 205.20 |
| Normalized EBITDA | - | 647.30 | 754.30 | 681.90 | 261.10 |
| EBIT | - | 478.30 | 546.30 | 435.70 | -29.60 |
| Interest Income | - | 14.10 | 43.90 | 56.10 | 25.30 |
| Interest Expense | - | 117.50 | 154.20 | 155.20 | 143.30 |
| Net Interest Income | - | -103.60 | -110.80 | -99.50 | -118.30 |
| Other Income Expense | - | -7 | -50 | -80.50 | -55.90 |
| Interest Income Non Operating | - | 14.10 | 43.90 | 56.10 | 25.30 |
| Interest Expense Non Operating | - | 117.50 | 154.20 | 155.20 | 143.30 |
| Net Non Operating Interest Income Expense | - | -103.60 | -110.80 | -99.50 | -118.30 |
| Pretax Income | - | 360.80 | 392.10 | 280.50 | -172.90 |
| Tax Provision | - | 85.50 | 157.10 | 118.30 | 33.50 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | -1.66 | -20 | -16.90 | -11.74 |
| Net Income Continuous Operations | - | 275.30 | 235 | 162.20 | -206.40 |
| Net Income From Continuing And Discontinued Operation | - | 275.30 | 235 | 162.20 | -206.40 |
| Net Income From Continuing Operation Net Minority Interest | - | 275.30 | 235 | 162.20 | -206.40 |
| Net Income | - | 275.30 | 235 | 162.20 | -206.40 |
| Net Income Common Stockholders | - | 275.30 | 235 | 162.20 | -206.40 |
| Net Income Including Noncontrolling Interests | - | 275.30 | 235 | 162.20 | -206.40 |
| Normalized Income | - | 280.64 | 265 | 225.80 | -162.24 |
| Diluted NI Availto Com Stockholders | - | 275.30 | 235 | 162.20 | -206.40 |
| Basic Average Shares | - | 401 | 366.30 | 371.80 | 375.80 |
| Diluted Average Shares | - | 401.60 | 366.80 | 372.10 | 375.80 |
| Reconciled Depreciation | - | 162 | 158 | 165.70 | 234.80 |
| Reconciled Cost Of Revenue | - | 735.70 | 718.50 | 692.10 | 758.50 |
| Total Unusual Items | - | -7 | -50 | -80.50 | -55.90 |
| Total Unusual Items Excluding Goodwill | - | -7 | -50 | -80.50 | -55.90 |
| Special Income Charges | - | 0 | -51.30 | -68.90 | -6.40 |
| Write Off | - | 0 | 51.30 | 68.90 | 6.40 |
| Impairment Of Capital Assets | 0 | 0 | 51.30 | - | - |
| Gain On Sale Of Security | - | -7 | 1.30 | -11.60 | -49.50 |
| General And Administrative Expense | - | 332.40 | 303.50 | 288.70 | 619.10 |
| Other Gand A | - | 332.40 | 303.50 | 288.70 | 619.10 |
| Total Other Finance Cost | - | 0.20 | 0.50 | 0.40 | 0.30 |
| Selling And Marketing Expense | - | 603.70 | 585.70 | 705 | 949.80 |
